2008 annual financial data
Celldex Therapeutics 2008 Net margin
Direct answer
Net margin was -637.12%.
Operating income was -34,000,080 USD and net income was -47,500,571 USD.
Operating cash flow was 18,280,766 USD.
Get free Celldex Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,455,507 USD
- Operating income
- -34,000,080 USD
- Net income
- -47,500,571 USD
- Operating cash flow
- 18,280,766 USD
Explore related company data
View all 2008 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Celldex Therapeutics financial years